Great Point Partners LLC Sarepta Therapeutics, Inc. Transaction History

Great Point Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $5.73 Million - $10.6 Million	-85,200 Reduced 51.57%	80,000 $7.71 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $4.26 Million - $5.14 Million	41,600 Added 33.66%	165,200 $20 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $13.2 Million - $19.4 Million	123,600 New	123,600 $14.2 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $7.36 Million - $9.65 Million	73,000 New	73,000 $9.46 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $12.2 Million - $17.1 Million	193,900 New	193,900 $14.5 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $9.18 Million - $13.1 Million	-145,405 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $11.2 Million - $14.5 Million	145,405 New	145,405 $13.1 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $11.9 Million - $14.2 Million	-250,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $8.93 Million - $11.8 Million	250,000	250,000 $11.3 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.